Testing effectiveness (Phase 2)Study completedNCT00258310
What this trial is testing
Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo
Who this might be right for
Head and Neck Cancer
Barbara Ann Karmanos Cancer Institute 35